|
|
675 RT 1
North Brunswick, NJ 08902
phone:917-519-3093
fax:
|
|
| Symbol |
Private |
| Founded |
2009 |
| Employees |
2 |
|
|
| www.pcasso.org
|
|
| Research Sector |
Medical Devices & Tech |
|
 |
| Summary Description |
| Developing the next generation contrast agents. |
|
| Management |
| Samir Tari, MD; Gregory van Kipnis, MBA |
| |
|
|
| |
|
| Keywords |
| Diagnostics, blood retinal barrier dysfunction, PolyChromatic Angiography, ophthalmology |
|
|
|
| Description |
|
PCAsso Diagnostics LLC. is a privately owned, research and development diagnostics company located in New Jersey. PCAsso is committed to the identification and development of novel medical diagnostic technologies.
We are currently developing PolyChromatic Angiography (PCA) a new diagnostic tool for diseases of the retina that we expect to be a "best-in-class"/ "next generation" product. The same proprietary concept of PCA can be used, with modifications, to diagnose diseases in other organ systems including the kidney, the brain and different kinds of cancer. |
|
| Products / Services |
PCAsso is developing PolyChromatic Angiography (PCA), the next generation angiography. PCA is a novel imaging technology that will provide quantitative information on the leakage of the retinal blood vessel. The granular information provided by PCA will help ophthalmologists better grade the disease severity and tailor treatment accordingly, thus preventing both under-treatment and over-treatment.
PCA will be adapted for the use in other diseases and organs including solid tumors, kidney and CNS.
|
|
| Technology / Differentiation |
| First in class: Quantitative angiography; |
|
| Market / Customers |
Diabetic Retinopathy, Age-related Macular Degeneration, Uveitis, Retinal Vein Occlusion
|
|
| Competitors / Substitutes / Alternatives |
Fluorescein Angiography,
Indocyanine Green Angiography
|
|
| Status |
| Pre-clinical development |
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members